SW-684 Cells
US$ 550,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | The SW 684 cell line was initiated by A. Leibovitz in 1974 at the Scott and White Clinic, Temple, Texas from a fibrosarcoma removed from a 68 year old male Caucasian. |
|---|---|
| Organismo | Human |
| Tecido | Connective tissue |
| Doença | Fibrosarcoma |
| Sinônimos | SW684, SW 684 |
Características
| Idade | 68 years |
|---|---|
| Gênero | Male |
| Etnia | Caucasian |
| Morfologia | Fibroblast-like |
| Propriedades de crescimento | Adherent |
Dados regulatórios
| Referência | SW-684 (Cytion catalog number 300422) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 9606 |
| Número de acesso do Cellosaurus | CVCL_1726 |
Dados biomoleculares
| Isoenzimas | G6PD, B, PGM1, 1-2, PGM3, 1, AK-1, 1-2, GLO-1, 2, Phenotype Frequency Product: 0.0055 |
|---|---|
| Tumorigênico | Yes, produces tumors in nude mice consistent with fibrosarcoma |
| Cariótipo | Hypertriploid. Modal number = 73, range = 59 to 79. The rate of higher ploidies was 9.1%. Eleven markers were common to most cells. These include: der(2)t(2,6)(p13,q13), der(12)t(8,12)(q11,q24), t(15q21q), 19q+, t(8p21q?) and six others. Of these, the der(2) and t(8p21q?) were generally paired. A few cells had double minutes (DM)(one per cell when present).There were 4 copies of N1, N18, N20 and N22 in most cells. Normal 15 and Y were absent. The x was paired in all cells. |
Manuseio
| Meio de cultura | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reagente de dissociação | Accutase |
| Subcultura | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Renovação de fluidos | 2 to 3 times per week |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de Análise (CoA)
| Número do lote | Tipo de certificado | Data | Número de catálogo |
|---|---|---|---|
| 300422-613 | Certificado de Análise | 23. May. 2025 | 300422 |
| 300422-220525 | Certificado de Análise | 21. Jul. 2025 | 300422 |
-
Produtos relacionados
Produtos relacionados
SW480 CellsOrganismo Human Tecido Colon Doença Adenocarcinoma, Grade IV, Dukes' type B. US$ 395,00*